Discovery to Market articles shed light on the commercial side of research, from the usefulness of graphene to the process and costs involved in drug development.
‘Me-too’ or ‘follow-on’ drugs are the copycats of the drug discovery landscape. Taking inspiration from existing drugs and making small modifications to them, many new therapies have been developed in this manner. Despite their reputation for lacking novelty and innovation,...
The AIDS/HIV pandemic of 1981 took everyone by surprise. In the U.S., the FDA and pharmaceutical companies raced to test the effectiveness of drug candidates like AZT in clinical trials. Many patients turned to unproven, unregulated and illegal treatments like...
Half a billion people today suffer from diabetes – a disease that causes high blood glucose levels. While many diseases remain untreatable, this isn’t the case with diabetes. The remarkable discovery and subsequent development of insulin injections have saved and...
The discovery of graphene back in 2004 brought about the prospect of exciting new possibilities. Light as a feather yet stronger than Kevlar, many believed graphene to be a wonder material, capable of changing the world the same way the...